Trajectories of anxiety among breast cancer patients treated with chemotherapy pre- and post-chemotherapy compared to healthy controls: A nationwide multicenter study. This is an ASCO Meeting Abstract ...
Exercise was shown to reduce chemotherapy-induced peripheral neuropathy in ovarian cancer survivors, according to findings from a recent study. Exercise may improve symptoms related to ...
PHOENIX — Chemotherapy-induced peripheral neuropathy (CIPN) is linked to a decline in executive and neuromuscular function, a new finding that may increase the risk for compromised mobility and fall ...
Many cancer patients with chemotherapy-induced peripheral neuropathy (CIPN) will develop a chronic form of the disorder, according to findings from a systematic review and meta-analysis. For more than ...
Please provide your email address to receive an email when new articles are posted on . Nearly half of women cancer survivors continued to experience symptoms of chemotherapy-induced peripheral ...
Chicago, Feb. 06, 2026 (GLOBE NEWSWIRE) -- The global chemotherapy-induced peripheral neuropathy Market is estimated to grow at a CAGR of 5.16% during the forecast period 2022-2030 ...
WOBURN, Mass., Dec. 05, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) noted publication of results from a NIH-funded clinical trial of Quell titled "Wireless transcutaneous electric nerve ...
Chemotherapy-induced peripheral neuropathy affects many patients with cancer, so CURE spoke with an expert about coping strategies for those who have developed this condition. Many patients who ...
Editor's Note: The American Society of Clinical Oncology (ASCO ®) issued new guidelines on the prevention and management of chemotherapy-induced peripheral neuropathy (CIPN) on April 14, 2014, [1] as ...
Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer A secondary data analysis of 512 women cancer survivors (age, 62 ± 6 years; ...
Chemotherapy-induced peripheral neuropathy (CIPN), characterized by pain, numbness, and tingling. Researchers sought to determine how subjective measures of CIPN correlated with objective measures of ...
CHELMSFORD, Mass. & NOVI, Mich. & DÜSSELDORF, Germany & TOKYO--(BUSINESS WIRE)-- Asahi Kasei Pharma has started trial drug administration in a Phase III study of ART-123 in Japan (generic name: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results